Loading clinical trials...
Loading clinical trials...
Approximately 1% of the general population will be affected by schizophrenia over the course of their lives, with life expectancy being reduced by 20 years on average and quality of life being severel...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Centre Hospitalier St Anne
NCT06456983 · Schizophrenia, Treatment Resistant Schizophrenia
NCT07404319 · Schizophrenia, Treatment Resistant Schizophrenia, and more
NCT05766540 · Difference in the Change in Cardiovascular Risk in Treatment Resistant Schizophrenia
NCT05167942 · Treatment Resistant Schizophrenia Based on the DTMS
Groupe Hospitalo-Universitaire Paris Psychiatrie & Neurosciences
Paris
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions